Cargando…

Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls

BACKGROUND: Germline mutations in the BRCA1 gene predispose to the development of breast cancer, exhibiting a specific histological phenotype. Identification of possible hallmarks of these tumors is important for selecting patients for genetic screening and provides inside in carcinogenetic pathways...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Voss, Marise R Heerma, van der Groep, Petra, Bart, Jos, van der Wall, Elsken, van Diest, Paul J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862041/ https://www.ncbi.nlm.nih.gov/pubmed/20398395 http://dx.doi.org/10.1186/1471-2407-10-145

Ejemplares similares

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
por: Heerma van Voss, Marise R., et al.
Publicado: (2011)

Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression
por: Hyseni, Agon, et al.
Publicado: (2011)

Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011)

HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
por: van der Groep, Petra, et al.
Publicado: (2013)

Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast
por: Kuijper, Arno, et al.
Publicado: (2005)

Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related
por: Bos, Reinhard, et al.
Publicado: (2004)

miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers
por: Vos, Shoko, et al.
Publicado: (2015)

Immunophenotyping invasive breast cancer: paving the road for molecular imaging
por: Vermeulen, Jeroen F, et al.
Publicado: (2012)

Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer
por: Vermeulen, Jeroen F., et al.
Publicado: (2013)

No Amplifications of Hypoxia-Inducible Factor-1α Gene in Invasive Breast Cancer: A Tissue Microarray Study
por: Vleugel, Marije M., et al.
Publicado: (2004)

The prognostic effect of DDX3 upregulation in distant breast cancer metastases
por: Heerma van Voss, Marise R., et al.
Publicado: (2016)

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer
por: Heerma van Voss, Marise R, et al.
Publicado: (2017)

Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma
por: Seeber, Laura MS, et al.
Publicado: (2010)

Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2007)

Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer
por: Bol, Guus M., et al.
Publicado: (2013)

Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer
por: van Voss, Marise R. Heerma, et al.
Publicado: (2015)

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
por: Vos, Shoko, et al.
Publicado: (2017)

Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer
por: Vermeulen, Jeroen F., et al.
Publicado: (2012)

p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice
por: Tenhagen, Milou, et al.
Publicado: (2016)

Targeting DDX3 with a small molecule inhibitor for lung cancer therapy
por: Bol, Guus M, et al.
Publicado: (2015)

Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer
por: Warmoes, Marc, et al.
Publicado: (2016)

Role of DDX3 in the pathogenesis of inflammatory bowel disease
por: Tantravedi, Saritha, et al.
Publicado: (2017)

Low Levels of BNIP3 Promoter Hypermethylation in Invasive Breast Cancer
por: van Diest, Paul J., et al.
Publicado: (2010)

p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast
por: Ercan, Cigdem, et al.
Publicado: (2012)

Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features
por: Koop, Esther A, et al.
Publicado: (2009)

Prognostic Value of Mitotic Index and Bcl2 Expression in Male Breast Cancer
por: Lacle, Miangela M., et al.
Publicado: (2013)

Lympho-Sarcoma
por: Brimhall, S. D.
Publicado: (1890)

Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice
por: de Groot, Jolien S., et al.
Publicado: (2017)

Receptor conversion in distant breast cancer metastases
por: Hoefnagel, Laurien DC, et al.
Publicado: (2010)

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer
por: Moelans, Cathy B., et al.
Publicado: (2018)

Comparison of Different Promoter Methylation Assays in Breast Cancer
por: Suijkerbuijk, Karijn P. M., et al.
Publicado: (2010)

Expression of Connective Tissue Growth Factor in Male Breast Cancer: Clinicopathologic Correlations and Prognostic Value
por: Lacle, Miangela M., et al.
Publicado: (2015)

Lympho-vascular invasion impacts the prognosis in breast-conserving surgery: a systematic review and meta-analysis
por: Zhong, Yi-Ming, et al.
Publicado: (2022)

Lympho-Sarcoma of Ileum
por: Stevens, A. E.
Publicado: (1939)

Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management
por: Moelans, Cathy B, et al.
Publicado: (2019)

Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports
por: van Dooijeweert, Carmen, et al.
Publicado: (2020)

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2019)

Significant inter‐ and intra‐laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2019)

Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization
por: Kijanka, Marta M., et al.
Publicado: (2016)

Conditional Inactivation of HIF-1 Using Intrabodies
por: Groot, Arjan J., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rqemh6451atai9gp39qdm5318r